Home > Arts > Digital Therapeutics Market Industry Analysis, Size, Share, Growth, Trends and Forecast

Digital Therapeutics Market Industry Analysis, Size, Share, Growth, Trends and Forecast

Added: (Thu Jun 13 2019)

Pressbox (Press Release) - According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.
Get Sample Copy for more Professional and Technical insights at : https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.asp
The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.
Browse and in-depth TOC on "Digital Therapeutics Market"
148 - Tables
36 - Figures
Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:

The digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms. Each segment has different market players and market leaders. For instance, the prediabetes market was led by Omada in 2015. Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease. Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program. The company has succeeded in securing heavy investments which it channelizes into the development, enhancement, and commercialization of its product.

Make an Inquiry Prior To Purchase this research study at: https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html

Submitted by:+1-888-600-6441
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.